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ABSTRACT 
Intrauterine growth restriction (IUGR) reduces skeletal muscle mass in fetuses and offspring. 
The objective of this study was to determine if myoblasts (skeletal muscle stem cells) from 
maternal inflammation induced intrauterine growth-restricted (MI-IUGR) fetuses are less 
responsive to proliferation-stimulating factors in culture. Ovine MI-IUGR fetal myoblasts were 
isolated at 125 days of gestational age (dGA, term = 150 dGA), grown for 72 hours in complete 
growth media spiked with insulin, tumor necrosis factor α (TNFα), or unspiked (basal), and 
analyzed for ex vivo proliferative capacity via a 2 hour EdU pulse. A second set of myoblasts 
were differentiated in differentiation media (2% fetal bovine serum) for 96 hours. MI-IUGR 
reduced (p < 0.05) fetal weight by ~22% at 125dGA compared to controls. No interacting effects 
of experimental group x media condition were observed for proliferation or differentiation rates. 
MI-IUGR increased (p < 0.05) myoblast ex vivo proliferation rates relative to controls 
independent of media condition. Incubation with insulin increased (p < 0.05) ex vivo myoblast 
proliferation rates independent of experimental group. No differences in proliferation rates were 
observed in media spiked with TNFα compared to basal media. The response to insulin and the 
lack of response to TNFα for proliferation indicate that fetal myoblast proliferation is not 
responsive to the effects of cytokines during this stage of development. MI-IUGR myoblasts 
exhibited diminished (p < 0.05) biomarkers for ex vivo differentiation rates. The early 
differentiation marker, myogenin, was present in fewer (p < 0.06) MI-IUGR myoblasts following 
4d differentiation relative to controls; the late differentiation marker, desmin, was also expressed 
by fewer (p < 0.05) MI-IUGR myoblasts relative to controls regardless of media condition. 
Fewer cells (p < 0.05) cultured in TNFα-spiked media stained positive for desmin relative to 
basal and insulin media treatments, regardless of experimental group, indicating that myoblast 
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differentiation is responsive to cytokines at the fetal stage. Based on these findings, we conclude 
that MI-IUGR creates intrinsic fetal myoblast dysfunction that interferes with their ability to exit 
the cell cycle (proceed from proliferation to differentiation), which results in their reduced 
capacity to facilitate muscle growth. This helps to explain the hallmark reduction in muscle mass 
observed in IUGR-born livestock and humans.  
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INTRODUCTION 
Livestock subjected to intrauterine growth restriction (IUGR)-inducing conditions exhibit not 
only low birth weight, but also increased neonatal mortality, reduced growth efficiency, and 
diminished carcass yield and quality (Beede et al., 2019). Maternal stressors that cause 
inflammation (e.g. heat stress, maternal overnutrition, illness, maternal undernutrition) cause 
placental insufficiency that harshens the intrauterine environment by inducing hypoxia and 
nutrient lack in the third trimester (Yates et al., 2011). This insufficiency reduces muscle mass by 
impairing fiber growth (Yates et al., 2012), as the limited nutrients are directed away from 
developing skeletal muscle and reappropriated to support vital fetal brain and heart development 
and growth (Hales and Barker, 2001). Chronic fetal stress during IUGR conditions leads to 
adaptive metabolic function by skeletal muscle (Cadaret et al., 2018). Maternal inflammation- 
induced IUGR (MI-IUGR) fetuses have restricted skeletal muscle growth that in other IUGR 
models is associated with myoblast dysfunction (Yates et al., 2014). Myoblasts are the rate-
limiting step for late gestational and postnatal skeletal muscle growth (Yates et al., 2012). In 
these stages of development, skeletal muscle grows via myofiber hypertrophy during which 
muscle stem cells called myoblasts undergo proliferation and differentiation steps followed by 
fusion with existing myofibers (Greenwood et al., 1999). Myoblast departure from the 
proliferation step is marked by the expression of the early regulatory factor myogenin, and 
completion of the differentiation step is marked by the presence of the late structural protein 
desmin, exhibited when fusion capacity is achieved (Rantanen et al., 1995; Yates et al., 2014). 
Furthermore, myoblast progression through these stages is regulated in part by inflammatory 
cytokines including TNFα, which circulate at higher concentrations in IUGR fetuses (Makikallio 
et al., 2014; Cadaret et al., 2019). TNFα stimulates proliferation of myoblasts but suppresses 
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their differentiation and fusion with myofibers (Kumar et al. 2012; Yates et al., 2018). Elevated 
cytokine concentrations also impact the responsiveness to insulin (Cadaret et al., 2018), causing 
fetal skeletal muscle cells to compensate by increasing insulin receptor expression. IUGR 
triggers a series of metabolic adaptations (Brown et al., 2015) including the increased use of 
amino acids as substrates for oxidation to maintain energy production (Thorn et al., 2011). 
Myofiber neogenesis ceases before parturition in most mammalian species, so postnatal muscle 
fiber repair and growth is facilitated by myoblast incorporation into existing fibers (Messina and 
Cossu, 2009). As described by Yates et al. (2018), IUGR-influenced myoblast adaptations persist 
into adulthood and carry with them consequences for metabolic health in humans (predisposition 
to diabetes and metabolic syndrome) and production performance in livestock (growth 
rate/efficiency, muscle mass, carcass quality). Thus, the objective of this study was to determine 
the impact of MI-IUGR during the proliferation and differentiation stages of fetal myoblast 
development in order to better understand the mechanism of adaptation and potentially identify a 
target for therapeutic treatment. 
 
MATERIALS AND METHODS 
Animal Model of IUGR 
All experiments were approved by the Institutional Animal Care and Use Committee at the 
University of Nebraska- Lincoln, which is accredited by AAALAC International. Timed-mated 
Polypay ewes were given intravenous injections of lipopolysaccharide from E. coli 055:B5 
(Sigma-Aldrich) every 3rd day from dGA 100 to 115 to induce maternal inflammation and 
produce the MI-IUGR fetal conditions which are described in Cadaret et al. (2019). Controls 
were produced from pair fed ewes injected with an equal volume of physiological saline.  
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Primary Myoblast Isolations 
At dGA125, fetal necropsies were performed after ewes were euthanized by double barbiturate 
overdose. Hindlimb muscles were collected, minced, washed in PBS, and suspended in PBS with 
Protease type XIV S. griseus (Sigma-Aldrich; St. Louis, MO) for a 1-hr enzymatic digestion to 
liberate myoblasts as previously described (Yates et al., 2014). The cells were isolated by serial 
centrifugation, preplated to remove fibroblasts, and plated on culture plates. After an overnight 
expansion period in complete growth media (Dulbecco’s modified eagle serum, DMEM; Gibco 
+ 20% fetal bovine serum, FBS; Atlas Biologicals), cells were slowly frozen and stored in liquid 
nitrogen. 
Myoblast Culture Experiments 
Myoblasts were rapidly thawed at 37℃ and preplated in DMEM + 10% FBS to purify and 
expand populations. They were then plated onto fibronectin coated 6-well tissue culture plates at 
5,000 cells well-1. Cells were incubated for 24 hours in complete growth media (DMEM + 20% 
FBS) containing no additive (basal), insulin (5mU/mL; HumulinR; Lilly; Indianapolis, IN), or 
TNFα (20ng/mL; Sigma). Myoblasts were then pulse-labeled with EdU (10mM, Qiagen) for 2 
hours and fixed in suspension with 4% PFA for 10 minutes. Following the protocol outlined by 
Posont et al. (2018), myoblasts that had replicated during the 2-hr pulse (i.e. EdU+) were 
identified by staining in suspension (ClickIT EdU) followed by analysis on a zEPI flow 
cytometer (ORFLO Technologies) with gates set from negative (non-stained) controls. An 
additional set of myoblasts were plated and cultured for 4 days in differentiation media (DMEM 
+ 2% FBS) with the same media conditions described above. Differentiated myoblasts were 
identified by positive staining for myogenin (F5B; 1:50; BD Pharmingen) or desmin (DE-U-10; 
1:250; GeneTex) and analyzed by zEPI flow cytometry as described above. 
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RESULTS 
Fetal biometry at necropsy 
Maternofetal inflammation reduced (p < 0.05) dGA-125 fetal weight in MI-IUGR fetuses (2.53 ± 
0.28 kg) relative to control fetuses (3.23 ± 0.18 kg) by ~22%. This is consistent with other sheep 
models of IUGR (Beede et al., 2019). Moreover, brainweight-to-bodyweight ratio was greater (p 
< 0.05) for MI-IUGR fetuses, demonstrating asymmetric growth restriction. All other 
morphometric and physiological data are reported by Cadaret et al. (2019).  
Fetal Myoblast Proliferation Rates 
No interaction was observed between experimental group and media condition for ex vivo 
myoblast proliferation rates. (See Figure 1.) MI-IUGR increased (p = 0.03) proliferation rates by 
~5%, regardless of media condition. Incubation in insulin-spiked media increased (p < 0.001) 
proliferation rates compared to incubation in basal media, regardless of experimental group. 
Incubation in TNFα-spiked media did not affect proliferation rates compared to basal media, 
regardless of experimental group. 
Fetal Myoblast Differentiation Rates 
No interaction was observed between experimental group and media condition for ex vivo 
myoblast differentiation rates. (See Figure 2.) MI-IUGR reduced (p < 0.05) the percentage of 
cells staining positive for myogenin, a marker for early differentiation, indicating that fewer 
myoblasts were reaching this stage of differentiation after 4 days in differentiation media. 
Furthermore, MI-IUGR reduced (p < 0.05) the percentage of cells staining positive for desmin, a 
marker for late differentiation. The percentages of myogenin-positive cells did not differ among 
media conditions, but incubation in TNFα-spiked media reduced (p < 0.001) the percentage of 
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cells staining positive for desmin compared to incubation in basal media, regardless of 
experimental group. 
 
DISCUSSION AND CONCLUSION 
In this study, we found that MI-IUGR fetal myoblasts proliferate at greater rates and differentiate 
at reduced rates regardless of whether they are being stimulated by insulin, TNFα, or are in an 
unstimulated state. The observation of these changes in culture indicates that they are the result 
of intrinsic myoblast deficits and not the in vivo fetal conditions. Insulin increased rate of 
proliferation in myoblasts from all fetuses to a similar magnitude, indicating that the deficit is not 
necessarily a disruption in insulin signaling. TNFα stimulation had no effect on proliferation 
rates, indicating that proliferative mechanisms may be less responsive to inflammatory cytokines 
in fetal compared to adult myoblasts (Kumar et al., 2012). Conversely, TNFα inhibited late 
differentiation, which indicates that fetal mechanisms responsible for differentiation are 
responsive to cytokines but are not altered in IUGR fetuses. Further investigation is warranted to 
determine the mechanistic cause of this reduction in IUGR fetal myoblast function. Based on 
these findings, we conclude that MI-IUGR induces adaptive dysfunction that interferes with the 
ability of fetal myoblasts to proceed from proliferation into the differentiation stage, which 
results in their reduced capacity to facilitate muscle growth. This helps to explain the hallmark 
reduction in muscle mass observed in IUGR-born humans and livestock (Hales and Barker, 
2001; Yates et al., 2014). Further study of IUGR myoblast differentiation may help elucidate the 
molecular mechanisms underlying this inability to exit the cell cycle, which in turn would 
provide a potential therapeutic target to improve muscle growth in IUGR offspring. Future areas 
of study may include the postulated desensitization of fetal myoblasts to inflammatory cytokines 
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in which chronic exposure induces changes in signaling pathways that eventually limit the ability 
to respond to cellular signals for differentiation. Alternatively, they may reveal the postulated 
hyper-sensitization of fetal myoblasts to pro-inflammatory cytokines in which MI-IUGR fetal 
myoblasts do not respond to growth signals due to enhanced inhibitory regulation by 
inflammatory factors. The MI-IUGR model differs slightly from the well characterized 
hyperthermia-induced placental insufficiency IUGR (PI-IUGR) model described in Yates et al. 
(2014). In the PI-IUGR model, IUGR fetal myoblasts exhibited reduced (p < 0.05) proliferation 
compared to the control group, which ultimately led to reduced numbers of differentiated 
myoblasts available for use in myogenesis (Yates et al., 2014). This study observed the opposite 
effect of IUGR on myoblast proliferation rates, perhaps due to the milder fetal growth restriction 
effects of MI-IUGR compared to those of PI-IUGR. Generally, however, similar metabolic 
dysfunction and impaired muscle growth have been observed in the two models (Beede et al., 
2019).  
 
In conclusion, identifying and targeting the adaptive mechanisms initiated by IUGR could lead to 
the development of the previously mentioned therapeutic treatments to counter the negative 
effects and restore normal muscle growth and development with far-reaching implications for the 
livestock industry. Reduction of neonate death loss, treatment of low birthweight individuals 
resulting in normal skeletal muscle growth, and improved metabolic efficiency would translate to 
decreased expense and increased production efficiency on the part of the producer for the 
ultimate benefit of all parties. 
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Figures  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Ex vivo proliferation rates of myoblasts isolated from MI-IUGR fetal sheep. Data are 
shown for control (n = 9) and MI-IUGR (n = 7) fetuses. 
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Figure 2. Ex vivo differentiation rates of myoblasts isolated from MI-IUGR fetal sheep. Data are 
shown for control (n = 9) and MI-IUGR (n = 7). A. represents % of myoblasts staining positive 
for myogenin; B. represents % of myoblasts staining positive for desmin.  
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